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Introduction
Lower-limb peripheral arterial disease is a type of cardiovascular 
disease in which the blood vessels (arteries) that carry blood 
to the legs and feet are hardened and narrowed or blocked by 
the build-up of fatty plaques (called atheroma). It affects around 
13% of adults over 50 years old, and major risk factors for its 
development include smoking, diabetes mellitus and dyslipidaemia 
(Morley et al., 2018). The presence of peripheral arterial disease 
itself is also a risk factor for other cardiovascular problems, such 
as angina, heart attack and stroke. This is because the underlying 
disease process, atherosclerosis, is a systemic 
process, meaning that blood vessels elsewhere in the 
body may also be affected. 
The most common symptom of peripheral arterial 
disease is intermittent claudication (IC), which is 
muscle pain or discomfort in the legs and/or buttocks 
brought on by walking and relieved within minutes 
on rest (see Figure 1). IC occurs due to an inability to 
sufficiently increase blood flow (and oxygen delivery) 
to match the metabolic demands of the lower-limb 
muscles during exercise and can cause marked 
reductions in functional capacity and quality of life 
(Morley et al., 2018). The walking distance or speed 
at which symptoms occur depends on multiple factors 
including the severity and site of the arterial disease, 
walking pace, terrain, incline and footwear.
Treatments for IC, aimed at relieving symptoms and reducing 
the risk of further cardiovascular disease, include lifestyle changes 
(e.g. stopping smoking, exercising more), vasoactive drugs (e.g. 
naftidrofuryl oxalate) and revascularisation (i.e. angioplasty or 
bypass surgery). In 2012, the United Kingdom’s National Institute 
of Health and Care Excellence (NICE) published a clinical guideline 
on the management of peripheral arterial disease, which stated that 
a supervised exercise programme should be offered as a first-line 
therapy for IC (NICE, 2012). This statement provides an overview 
of the evidence on exercise training and recommendations for 
people delivering exercise programmes to this population. 
Evidence on exercise training
Core outcome measures
Walking ability and its impact on quality of life are the most 
important outcome measures of intervention to clinicians and 
patients. Measures of walking ability include pain-free and maximum 
walking distances (or times) obtained during standardised treadmill 
testing, and the distance covered in the 6-minute corridor walk 
test. The ‘Gardner’ treadmill test is commonly used, which 
involves a constant speed of 3.2 km/h and an increase in gradient 
of 2% every 2 minutes. Several generic and condition-specific 
questionnaires have been used to assess quality of life, including the 
SF-36 and VascuQol, respectively. 
Effects of exercise training on walking ability and quality of life
A recent Cochrane review concluded that there is high-quality 
evidence showing that exercise programmes (a variety of regimes) 
elicit important improvements in both pain-free and maximum 
walking distances compared with no-exercise control in people 
with IC (Lane et al., 2017). A meta-analysis of 9 trials (n=391) 
showed a mean between-group difference in pain-free walking
distance at follow-up of 82 m (95% CI 72-92 m; follow-up ranging 
6 weeks to 2 years). The corresponding difference for maximum 
walking distance was 120 m (95% CI 51-190 m; 10 trials, n=500). 
Improvements of this magnitude are likely to help with independence.
The same review also reported that there was moderate-quality 
evidence for improvements in physical and mental aspects of 
quality of life, as assessed using the SF-36 (Lane et al., 2017). A 
meta-analysis of data at 6 months of follow-up showed the physical 
component summary score to be 2 points higher in exercise 
versus control (95% CI 1-3; 5 trials, n=429). The corresponding 
difference for the mental component summary score was 4 points 
(95% CI 3-5; 4 trials, n=343). Again, such differences have the 
potential to be clinically meaningful.
Modes of exercise
In most studies, exercise programmes have involved treadmill or 
track walking of sufficient intensity to bring on claudication pain. 
There is a strong evidence base for this type of training and clinical 
guidelines around the world cite it as the preferred modality 
(e.g. NICE, 2012). Alternate exercise modalities have not been 
extensively studied. However, a randomised trial of 104 participants 
provided evidence that both cycling and arm-cranking are viable 
alternatives for improving walking distances (Zwierska et al., 2005). 
These modalities may be useful for patients who are unwilling or 
unable to walk because of the pain encountered. Resistance training 
may have a complementary role (e.g. for improving muscular 
strength); however, it should not be used as a substitute for aerobic 
exercise because its impact on walking distances appears modest 
(e.g. McDermott et al., 2009). 
Supervision
The systematic review of Gommans et al. (2014) reports the 
relationship between the ‘intensity’ of supervision of an exercise 
programme and the extent to which walking distances were 
improved. Thirty studies involving 1,406 people with IC were 
included. Study treatment arms were categorised according to 
type of support: no exercise, walking advice, home-based exercise 
and supervised exercise. The results indicated that the intensity 
of supervision was directly related to treatment effect, with 
supervised exercise training being superior to all other categories 
with respect to improvement in walking distances at all follow-ups 
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Figure 1. Intermittent claudication (IC) due to peripheral arterial disease. 
Reproduced from Peripheral artery disease (Morley et al., 2018) with permission from BMJ Publishing Group Ltd.  
Note: Iliac or femoral artery disease can cause symptoms at multiple distal muscle sites.
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(6 weeks, 3 months and 6 months). An economic 
evaluation to inform the NICE guidelines (NICE, 
2012) also indicated that supervised exercise is 
more cost-effective than either unsupervised 
exercise or angioplasty.
Safety
Gommans et al. (2015) explored the safety of 
supervised exercise training in people with IC by 
reviewing adverse event data from clinical trials. 
Seventy-four trials were included, representing 
82,725 hours of training in 2,876 participants.  
Eight adverse events were reported, six of 
cardiac and two of non-cardiac origin, resulting 
in an all-cause complication rate of one event per 
10,340 patient-hours. The authors concluded that 
supervised exercise training is safe for people with 
IC due to a low all-cause complication rate, and 
routine cardiac pre-screening is not required.
Mechanisms
The mechanisms underpinning the benefits of exercise training are 
incompletely understood. Regression of arterial stenoses appears 
unlikely to be implicated (Lane et al., 2017), whereas there are 
potential roles for improvements in maximum oxygen uptake, 
endothelial function, systemic inflammation and skeletal muscle 
oxidative capacity (Harwood et al., 2016). A summary of potential 
mechanisms is presented in Figure 2. 
 
Conclusions
• Exercise training is a safe, effective and low-cost intervention  
for improving walking ability in people with IC. Additional 
benefits may include improvements in quality of life and 
cardiovascular health.
• Clinical guidelines advocate exercise training as a primary therapy 
for IC. These guidelines also state that revascularisation or drug 
treatment options should only be considered if exercise training 
provides insufficient symptomatic relief.
Recommendations
• Patients should be clinically assessed and risk stratified to ensure 
that they do not have any contraindications to the exercise 
therapy and to document comorbidities that may need to be 
accounted for in the exercise programme. 
• Exercise should ideally be delivered through an on-site supervised 
programme with clinical oversight. However, a facilitated, 
self-managed exercise programme involving behaviour change 
techniques is a reasonable alternative for people who prefer this 
approach or are unable to access supervised exercise.
• Walking is the primary mode of exercise for improving walking 
ability and claudication symptoms. A structured programme of 
walking exercise at an intensity that elicits moderate-to-strong 
claudication pain should be conducted for a minimum of 3 
months, involving at least three, 30-60 minute sessions per week. 
• Further recommendations on exercise training are provided in a 
Supplementary Table, which can be accessed in the online version 
of this expert statement available at: www.bases.org.uk/spage-
resources-bases_expert_statements.html.
• Acute responses to exercise should be monitored to inform 
the exercise prescription, including heart rate, blood pressure, 
perceived exertion and claudication pain. 
• Programme entry and exit assessments should be performed 
to determine changes in patient-important outcomes, including 
walking distances and quality of life. 
Figure 2. Potential mechanisms underpinning the benefits of lower-limb endurance 
exercise training on walking distance in people with IC, the relative importance of which is 
incompletely understood.
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